DFFN

Diffusion Pharmaceuticals Inc.CIK 1053691 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for DFFN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for DFFN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
LANCHONEY DIANA M	Director	9	$0	$0	2023-06-30
Hollingsworth Jane H	Director	19	$20.0K	$0	2023-05-31
Cobuzzi Robert Joseph Jr.	President & CEO	31	$11.7K	$0	2023-01-31
JAEGER RAVEN	Chief Regulatory Officer	1	$0	$0	2022-06-07
ELDER WILLIAM ROBERT	GC & Secretary	9	$12.3K	$0	2022-04-18
GALLOWAY CHRISTOPHER D	Chief Medical Officer	4	$0	$0	2022-01-27
Hornung William Karl	Chief Financial Officer	5	$0	$0	2022-01-27
Giles Mark T	Director	13	$0	$0	2021-07-01
Adams Robert W	Director	9	$0	$0	2021-07-01
Francois Eric	Director	3	$0	$0	2021-07-01
LEVIN ALAN G	Director	9	$0	$0	2021-07-01
Byrne Thomas E	General Counsel	5	$0	$0	2020-01-07
Kalergis David G	Chairman and CEO	6	$0	$0	2020-01-02
Gainer John	Chief Scientific Officer	6	$0	$0	2020-01-02
RUFFOLO ROBERT R	Director	3	$0	$0	2018-06-14
Shealy Ben	Sr VP Finance & Treasurer	5	$0	$0	2018-01-02
BLECH ISAAC	Director	1	$0	$0	2016-08-31

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
LANCHONEY DIANA M	Director	M Exercise deriv	2023-06-30	2023-07-05	232	—	$0	928	SEC↗
LANCHONEY DIANA M	Director	D To issuer	2023-06-30	2023-07-05	85	—	$0	294	SEC↗
LANCHONEY DIANA M	Director	M Exercise	2023-06-30	2023-07-05	232	—	$0	379	SEC↗
Hollingsworth Jane H	Director	M Exercise deriv	2023-05-31	2023-06-02	183	—	$0	183	SEC↗
Hollingsworth Jane H	Director	D To issuer	2023-05-31	2023-06-02	68	—	$0	1,231	SEC↗
Hollingsworth Jane H	Director	M Exercise	2023-05-31	2023-06-02	183	—	$0	1,299	SEC↗
LANCHONEY DIANA M	Director	M Exercise deriv	2023-03-31	2023-04-03	232	—	$0	1,160	SEC↗
LANCHONEY DIANA M	Director	M Exercise	2023-03-31	2023-04-03	232	—	$0	232	SEC↗
LANCHONEY DIANA M	Director	D To issuer	2023-03-31	2023-04-03	85	—	$0	147	SEC↗
Hollingsworth Jane H	Director	M Exercise deriv	2023-02-28	2023-03-03	183	—	$0	366	SEC↗
Hollingsworth Jane H	Director	D To issuer	2023-02-28	2023-03-03	68	—	$0	1,116	SEC↗
Hollingsworth Jane H	Director	M Exercise	2023-02-28	2023-03-03	183	—	$0	1,184	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2023-01-31	2023-02-03	327	—	$0	0	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2023-01-31	2023-02-03	121	—	$0	1,616	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2023-01-31	2023-02-03	327	—	$0	1,737	SEC↗
Hollingsworth Jane H	Director	M Exercise deriv	2022-11-30	2022-12-02	183	—	$0	549	SEC↗
Hollingsworth Jane H	Director	M Exercise	2022-11-30	2022-12-02	183	—	$0	1,069	SEC↗
Hollingsworth Jane H	Director	D To issuer	2022-11-30	2022-12-02	68	—	$0	1,001	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2022-10-31	2022-11-02	327	—	$0	327	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2022-10-31	2022-11-02	121	—	$0	1,410	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2022-10-31	2022-11-02	327	—	$0	1,531	SEC↗
Hollingsworth Jane H	Director	M Exercise deriv	2022-08-31	2022-09-02	183	—	$0	732	SEC↗
Hollingsworth Jane H	Director	M Exercise	2022-08-31	2022-09-02	183	—	$0	954	SEC↗
Hollingsworth Jane H	Director	D To issuer	2022-08-31	2022-09-02	67	—	$0	886	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2022-08-01	2022-08-03	327	—	$0	654	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2022-08-01	2022-08-03	121	—	$0	1,204	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2022-08-01	2022-08-03	327	—	$0	1,325	SEC↗
JAEGER RAVEN	Chief Regulatory Officer	A Award deriv	2022-06-07	2022-08-26	8,000	—	$0	8,000	SEC↗
Hollingsworth Jane H	Director	M Exercise deriv	2022-05-31	2022-06-02	183	—	$0	915	SEC↗
Hollingsworth Jane H	Director	M Exercise	2022-05-31	2022-06-02	183	—	$0	838	SEC↗
Hollingsworth Jane H	Director	D To issuer	2022-05-31	2022-06-02	67	—	$0	771	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2022-05-02	2022-05-03	327	—	$0	981	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2022-05-02	2022-05-03	327	—	$0	1,119	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2022-05-02	2022-05-03	121	—	$0	998	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	C Conversion deriv	2022-04-18	2022-04-19	100	$25.00	$2.5K	0	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	C Conversion deriv	2022-04-18	2022-04-19	100	$25.00	$2.5K	0	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	C Conversion	2022-04-18	2022-04-19	100	$25.00	$2.5K	400	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	C Conversion	2022-04-18	2022-04-19	100	$25.00	$2.5K	792	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	P Buy deriv	2022-03-18	2022-03-22	5,000	$0.50	$2.5K	5,000	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	P Buy deriv	2022-03-18	2022-03-22	5,000	$0.50	$2.5K	5,000	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2022-01-31	2022-02-02	16,350	—	$0	65,400	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2022-01-31	2022-02-02	6,049	—	$0	34,602	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2022-01-31	2022-02-02	16,350	—	$0	40,651	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	A Award deriv	2022-01-27	2022-01-31	764,357	—	$0	764,357	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	A Award deriv	2022-01-27	2022-01-31	305,743	—	$0	305,743	SEC↗
GALLOWAY CHRISTOPHER D	Chief Medical Officer	A Award deriv	2022-01-27	2022-01-31	305,743	—	$0	305,743	SEC↗
Hornung William Karl	Chief Financial Officer	A Award deriv	2022-01-27	2022-01-31	305,743	—	$0	305,743	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2021-11-01	2022-02-02	16,350	—	$0	81,750	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2021-11-01	2022-02-02	16,350	—	$0	30,350	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	D To issuer	2021-11-01	2022-02-02	6,049	—	$0	24,301	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise deriv	2021-11-01	2021-11-03	16,350	—	$0	81,750	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	M Exercise	2021-11-01	2021-11-03	16,350	—	$0	30,350	SEC↗
LANCHONEY DIANA M	Director	A Award deriv	2021-07-01	2021-10-15	69,400	—	$0	69,400	SEC↗
LANCHONEY DIANA M	Director	A Award deriv	2021-07-01	2021-10-15	83,300	—	$0	83,300	SEC↗
LANCHONEY DIANA M	Director	A Award deriv	2021-07-01	2021-10-15	83,300	—	$0	83,300	SEC↗
Giles Mark T	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
Francois Eric	Director	A Award deriv	2021-07-01	2021-07-06	69,400	—	$0	69,400	SEC↗
Francois Eric	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
Francois Eric	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
Adams Robert W	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
LEVIN ALAN G	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
Hollingsworth Jane H	Director	A Award deriv	2021-07-01	2021-07-06	83,300	—	$0	83,300	SEC↗
Hollingsworth Jane H	Director	P Buy	2021-05-13	2021-05-17	32,786	$0.61	$20.0K	32,786	SEC↗
Hornung William Karl	Chief Financial Officer	A Award deriv	2021-03-01	2021-03-04	122,771	—	$0	122,771	SEC↗
Hornung William Karl	Chief Financial Officer	A Award deriv	2021-03-01	2021-03-04	80,069	—	$0	80,069	SEC↗
GALLOWAY CHRISTOPHER D	Chief Medical Officer	A Award deriv	2021-03-01	2021-03-04	81,537	—	$0	81,537	SEC↗
GALLOWAY CHRISTOPHER D	Chief Medical Officer	A Award deriv	2021-03-01	2021-03-04	27,180	—	$0	27,180	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	A Award deriv	2021-03-01	2021-03-04	62,522	—	$0	62,522	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	A Award deriv	2021-03-01	2021-03-04	87,684	—	$0	87,684	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	A Award deriv	2021-03-01	2021-03-04	161,139	—	$0	161,139	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	A Award deriv	2021-03-01	2021-03-04	53,713	—	$0	53,713	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	P Buy	2020-11-17	2020-11-18	5,000	$0.63	$3.1K	15,000	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	P Buy	2020-11-16	2020-11-18	10,000	$0.67	$6.7K	10,000	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	P Buy	2020-11-16	2020-11-18	14,000	$0.66	$9.2K	14,000	SEC↗
GALLOWAY CHRISTOPHER D	Chief Medical Officer	A Award deriv	2020-10-19	2020-10-21	200,000	—	$0	200,000	SEC↗
ELDER WILLIAM ROBERT	GC & Secretary	A Award deriv	2020-09-22	2020-10-14	70,000	—	$0	70,000	SEC↗
Cobuzzi Robert Joseph Jr.	President & CEO	A Award deriv	2020-09-08	2020-09-11	475,000	—	$0	475,000	SEC↗
Hollingsworth Jane H	Director	A Award deriv	2020-09-01	2020-10-01	54,900	—	$0	54,900	SEC↗
Hollingsworth Jane H	Director	A Award deriv	2020-09-01	2020-10-01	67,400	—	$0	67,400	SEC↗
LEVIN ALAN G	Director	A Award deriv	2020-06-17	2020-06-18	61,300	—	$0	61,300	SEC↗
Giles Mark T	Director	A Award deriv	2020-06-17	2020-06-18	61,300	—	$0	61,300	SEC↗
Cobuzzi Robert Joseph Jr.	Director	A Award deriv	2020-06-17	2020-06-18	61,300	—	$0	61,300	SEC↗
Adams Robert W	Director	A Award deriv	2020-06-17	2020-06-18	61,300	—	$0	61,300	SEC↗
Byrne Thomas E	General Counsel	A Award deriv	2020-01-07	2020-01-09	25,000	—	$0	25,000	SEC↗
Cobuzzi Robert Joseph Jr.	Director	A Award deriv	2020-01-07	2020-01-13	118,600	—	$0	118,600	SEC↗
Cobuzzi Robert Joseph Jr.	Director	A Award deriv	2020-01-07	2020-01-13	98,100	—	$0	98,100	SEC↗
Hornung William Karl	Chief Financial Officer	A Award deriv	2020-01-02	2020-01-30	52,600	—	$0	52,600	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2020-01-02	2020-01-30	262,900	—	$0	262,900	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2020-01-02	2020-01-30	239,400	—	$0	239,400	SEC↗
Giles Mark T	Director	A Award deriv	2019-06-13	2019-07-19	13,100	—	$0	13,100	SEC↗
LEVIN ALAN G	Director	A Award deriv	2019-06-13	2019-07-19	13,100	—	$0	13,100	SEC↗
Adams Robert W	Director	A Award deriv	2019-06-13	2019-07-19	13,100	—	$0	13,100	SEC↗
LEVIN ALAN G	Director	A Award deriv	2019-06-13	2019-08-06	19,200	—	$0	19,200	SEC↗
Giles Mark T	Director	A Award deriv	2019-06-13	2019-08-06	19,200	—	$0	19,200	SEC↗
Adams Robert W	Director	A Award deriv	2019-06-13	2019-08-06	19,200	—	$0	19,200	SEC↗
Byrne Thomas E	General Counsel	A Award deriv	2019-01-03	2019-01-30	2,667	—	$0	2,667	SEC↗
Hornung William Karl	Chief Financial Officer	A Award deriv	2019-01-02	2019-01-04	16,334	—	$0	16,334	SEC↗
RUFFOLO ROBERT R	Director	A Award deriv	2018-06-14	2018-06-18	40,000	—	$0	40,000	SEC↗
LEVIN ALAN G	Director	A Award deriv	2018-06-14	2018-06-18	40,000	—	$0	40,000	SEC↗
Giles Mark T	Director	A Award deriv	2018-06-14	2018-06-18	40,000	—	$0	40,000	SEC↗
Adams Robert W	Director	A Award deriv	2018-06-14	2018-06-18	40,000	—	$0	40,000	SEC↗
Giles Mark T	Director	A Award deriv	2018-01-02	2018-01-04	25,000	—	$0	25,000	SEC↗
Adams Robert W	Director	A Award deriv	2018-01-02	2018-01-04	25,000	—	$0	25,000	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2018-01-02	2018-01-04	55,000	—	$0	55,000	SEC↗
RUFFOLO ROBERT R	Director	A Award deriv	2018-01-02	2018-01-04	25,000	—	$0	25,000	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2018-01-02	2018-01-04	45,000	—	$0	45,000	SEC↗
LEVIN ALAN G	Director	A Award deriv	2018-01-02	2018-01-04	25,000	—	$0	25,000	SEC↗
Shealy Ben	Sr VP Finance & Treasurer	A Award deriv	2018-01-02	2018-01-04	25,000	—	$0	25,000	SEC↗
Byrne Thomas E	General Counsel	A Award deriv	2018-01-02	2018-01-04	10,000	—	$0	10,000	SEC↗
RUFFOLO ROBERT R	Director	A Award deriv	2017-06-29	2017-07-13	52,057	—	$0	52,057	SEC↗
LEVIN ALAN G	Director	A Award deriv	2017-06-15	2017-06-16	23,900	—	$0	23,900	SEC↗
Adams Robert W	Director	A Award deriv	2017-06-15	2017-06-16	23,900	—	$0	23,900	SEC↗
Giles Mark T	Director	A Award deriv	2017-06-15	2017-06-16	23,900	—	$0	23,900	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2017-05-10	2017-05-12	41,000	—	$0	41,000	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2017-05-10	2017-05-12	34,000	—	$0	34,000	SEC↗
Shealy Ben	Sr VP Finance & Treasurer	A Award deriv	2017-05-10	2017-05-12	23,100	—	$0	23,100	SEC↗
Shealy Ben	Sr VP Finance & Treasurer	A Award deriv	2017-05-10	2017-06-30	23,100	—	$0	23,100	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2017-05-10	2017-06-30	34,000	—	$0	34,000	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2017-05-10	2017-06-30	41,000	—	$0	41,000	SEC↗
Byrne Thomas E	General Counsel	A Award deriv	2017-01-03	2017-01-04	4,673	—	$0	4,673	SEC↗
Giles Mark T	Director	P Buy	2016-12-28	2016-12-28	290,580	—	$0	802,689	SEC↗
Giles Mark T	Director	J Other	2016-12-27	2016-12-28	290,580	—	$0	0	SEC↗
Giles Mark T	Director	P Buy	2016-12-15	2016-12-16	512,109	—	$0	512,109	SEC↗
Giles Mark T	Director	J Other	2016-12-14	2016-12-16	339,055	—	$0	290,580	SEC↗
LEVIN ALAN G	Director	A Award deriv	2016-12-08	2016-12-13	14,000	—	$0	14,000	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-12-08	2016-12-13	105,000	—	$0	105,000	SEC↗
Giles Mark T	Director	A Award deriv	2016-12-08	2016-12-13	14,000	—	$0	14,000	SEC↗
Shealy Ben	Sr VP Finance & Treasurer	A Award deriv	2016-12-08	2016-12-13	16,000	—	$0	16,000	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-12-08	2016-12-13	34,000	—	$0	34,000	SEC↗
Adams Robert W	Director	A Award deriv	2016-12-08	2016-12-13	14,000	—	$0	14,000	SEC↗
BLECH ISAAC	Director	A Award deriv	2016-08-31	2016-09-16	204,907	—	$0	204,907	SEC↗
Adams Robert W	Director	A Award deriv	2016-07-21	2016-07-25	58,473	—	$0	58,473	SEC↗
Giles Mark T	Director	A Award deriv	2016-07-21	2016-07-25	58,473	—	$0	58,473	SEC↗
LEVIN ALAN G	Director	A Award deriv	2016-07-21	2016-07-25	58,473	—	$0	58,473	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-05-16	2016-05-20	83,333	—	$0	83,333	SEC↗
Shealy Ben	Senior Vice President Financ	A Award deriv	2016-05-16	2016-05-20	89,583	—	$0	89,583	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-05-16	2016-05-20	204,167	—	$0	204,167	SEC↗
Byrne Thomas E	General Counsel	A Award deriv	2016-05-16	2016-05-20	16,667	—	$0	16,667	SEC↗